Skip to content

Role of homoeopathy in flu like illness.

Effectiveness of Influenzinum in prevention of Influenza like Illness (ILI) â?? A comparative cohort study-2018

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/12/016774
Enrollment
40000
Registered
2018-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Homoeopathic medicine Influenzinum 30.: Homoeopathic medicine Influenzinum 30 shall be distributed to apparently healthy persons.Dose for children below 12 years: Give 2 pills of medici

Sponsors

Central Council for Research in Homoeopathy New Delhi Ministry of AYUSH Government of india
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy individuals of either sex, aged 1 year and above living in the same community 2. Informed consent by the family head 3. No symptom of Influenza like illness (An acute respiratory infection with Fever > 38°C AND Cough) at the time of enrollment.

Exclusion criteria

Exclusion criteria: 1. People with symptoms of Influenza like illness/ fever in last 10 days which include 2. An acute respiratory infection with Fever > 38°C AND Cough 3. Pregnant women and lactating mother 4. Child below age of 1 year. 5. Individuals taking other preventive medicines for Influenza like illness 6. Patients with malignancy, immunocompromised state, life threatening diseases, end stage diseases.

Design outcomes

Primary

MeasureTime frame
To assess and compare changes in incidence of influenza like illness assessed through active surveillance on weekly basis till 3 months between the groups.Timepoint: Incidence of influenza like illness will be recorded during 3 months time.

Secondary

MeasureTime frame
1.To assess the changes in intensity and duration of illness. 2.To find the minimum effective dose.Timepoint: 1.Daily follow up till ILI episode ends. 2.At end of study.

Countries

India

Contacts

Public ContactDr RK Manchanda

Epidemic Cell, Central Council for Research in Homoeopathy

drdnayak@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026